Jamie E Chaft

24PUBLICATIONS
200CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Dec 19, 2025
Reply to: "NeoADAURA: Can We Afford to Overlook Objective Response Rates?" and "Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?"

Jamie E Chaft, Masahiro Tsuboi, Walter Weder

|Dec 05, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.

Sara A Walton, Justin J Kim, Francesco Paoloni

|Jul 24, 2025
Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Justin J Kim, Sara A Walton, Navin R Mahadevan

|Jun 02, 2025
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer.

Jianxing He, Masahiro Tsuboi, Walter Weder

Pageof 4